Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.

Treatment and survival rates of patients with non-small-cell lung cancer (NSCLC) were compared between three French Cancer Registries (Calvados, Doubs, Tarn). The methodological issues in such comparisons are discussed. The treatments for NSCLC differed between the regions: radiotherapy tended to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosclaude, P., Galat, J. P., Macé-Lesech, J., Roumagnac-Machelard, M., Mercier, M., Robillard, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033958/
https://www.ncbi.nlm.nih.gov/pubmed/7577482
_version_ 1782136951326900224
author Grosclaude, P.
Galat, J. P.
Macé-Lesech, J.
Roumagnac-Machelard, M.
Mercier, M.
Robillard, J.
author_facet Grosclaude, P.
Galat, J. P.
Macé-Lesech, J.
Roumagnac-Machelard, M.
Mercier, M.
Robillard, J.
author_sort Grosclaude, P.
collection PubMed
description Treatment and survival rates of patients with non-small-cell lung cancer (NSCLC) were compared between three French Cancer Registries (Calvados, Doubs, Tarn). The methodological issues in such comparisons are discussed. The treatments for NSCLC differed between the regions: radiotherapy tended to be preferred in Calvados (73% vs 21.3% surgery), whereas surgery was more frequently employed in Doubs and Tarn (27.7% and 37% respectively). The percentage of cases receiving no therapeutic treatment ranged from 7.8% (Calvados) to 26% (Tarn). Despite the differences in treatment, the overall survival rates were similar in the three regions. Adjustment for treatment in such a descriptive study may be misleading since different therapeutic strategies in different regions may lead to selection of patients of systematically better or poorer prognosis in the various treatment groups.
format Text
id pubmed-2033958
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20339582009-09-10 Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. Grosclaude, P. Galat, J. P. Macé-Lesech, J. Roumagnac-Machelard, M. Mercier, M. Robillard, J. Br J Cancer Research Article Treatment and survival rates of patients with non-small-cell lung cancer (NSCLC) were compared between three French Cancer Registries (Calvados, Doubs, Tarn). The methodological issues in such comparisons are discussed. The treatments for NSCLC differed between the regions: radiotherapy tended to be preferred in Calvados (73% vs 21.3% surgery), whereas surgery was more frequently employed in Doubs and Tarn (27.7% and 37% respectively). The percentage of cases receiving no therapeutic treatment ranged from 7.8% (Calvados) to 26% (Tarn). Despite the differences in treatment, the overall survival rates were similar in the three regions. Adjustment for treatment in such a descriptive study may be misleading since different therapeutic strategies in different regions may lead to selection of patients of systematically better or poorer prognosis in the various treatment groups. Nature Publishing Group 1995-11 /pmc/articles/PMC2033958/ /pubmed/7577482 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Grosclaude, P.
Galat, J. P.
Macé-Lesech, J.
Roumagnac-Machelard, M.
Mercier, M.
Robillard, J.
Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
title Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
title_full Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
title_fullStr Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
title_full_unstemmed Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
title_short Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.
title_sort differences in treatment and survival rates of non-small-cell lung cancer in three regions of france.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033958/
https://www.ncbi.nlm.nih.gov/pubmed/7577482
work_keys_str_mv AT grosclaudep differencesintreatmentandsurvivalratesofnonsmallcelllungcancerinthreeregionsoffrance
AT galatjp differencesintreatmentandsurvivalratesofnonsmallcelllungcancerinthreeregionsoffrance
AT macelesechj differencesintreatmentandsurvivalratesofnonsmallcelllungcancerinthreeregionsoffrance
AT roumagnacmachelardm differencesintreatmentandsurvivalratesofnonsmallcelllungcancerinthreeregionsoffrance
AT mercierm differencesintreatmentandsurvivalratesofnonsmallcelllungcancerinthreeregionsoffrance
AT robillardj differencesintreatmentandsurvivalratesofnonsmallcelllungcancerinthreeregionsoffrance

Ejemplares similares